SRC and neoplasm: Using a large cohort of ER-positive breast cancer patients treated with adjuvant tamoxifen we have shown that high levels of activated c-Src are present in over 50% of tumour specimens and we also show that nuclear c-src activation is significantly associated with improved overall and disease-free survival.